Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Axon showed 10% year-over-year EPS growth in the most recent quarter. Portfolio weighting is...
— Alan Breed
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Axon Enterprise, Inc.
The largest detractor from relative performance. Shares declined due...
Axon has transitioned successfully into a software-as-a-service model, utilizing evidence.com as an essential repository for law enforcement data. Despite high current...
Axon continues to exhibit exceptional operational performance and strong product innovation through offerings like DraftOne and its drone platform. Its substantial contracted...
More institutional theses from Edgewood Management
Nvidia and Eli Lilly are two examples from our portfolio. Nvidia spent years...
As the primary industry standard in consumer credit scoring, the company holds an incredibly durable market position. Recent regulatory headline...
Boasting a near-monopoly in crucial photolithography technology, the company is an essential beneficiary of secular semi-conductor growth. Short-term stock declines...